The most recent Success stories from EU Research. Select a theme or country from the menus on the left to see more articles
Health & life sciences
Tick (check) box to add article to PDF "basket"
EU-funded researchers are using the latest vaccine technologies and antigen discovery tools to develop a multi-stage, multi-antigen vaccine against Plasmodium falciparum, the parasite responsible for the deadliest form of malaria.
Published: 25 April 2018
Hundreds of millions of people each year are infected with Plasmodium vivax, the most widespread form of malaria worldwide. An EU-funded project is tackling the mosquito-borne parasite, leading cutting-edge research efforts to accelerate the development of effective vaccines.
Published: 25 April 2018
Using innovative nanotechnologies, an EU-funded project is developing more efficient and sustainable vaccine manufacturing processes. The cost of vaccines puts a brake on wider immunisation, so these new processes will find broad application - especially in developing economies.
Published: 19 February 2018
The virus that causes chickenpox can also lead to more serious and painful conditions in older people. An EU-funded researcher is discovering how the virus interacts with the immune system and, possibly, how it might be controlled.
Published: 14 November 2017
Published: 10 November 2017
An EU-funded project has developed new tests to quickly determine whether a respiratory tract infection is viral or bacterial and whether it shows resistance to antibiotics, helping doctors prescribe the right treatment for patients while curbing the overuse of such life-saving drugs.
Published: 23 June 2017
Published: 17 March 2016
How much do you know about the effects of glutamate on the frontostriatal circuits? Not as much as you'd like, possibly, but then again there is still a lot to learn. EU-funded researchers are studying the role of this neurotransmitter and potential genetic factors in the development of compulsive disorders such as autism, ADHD and OCD.
Published: 15 March 2016
When the nature of a disease is unknown, it is difficult to be prepared. Think Ebola, avian influenza or SARS - news reports of their spread were regularly accompanied by updates on the frantic hunt for vaccines and treatments. EU-funded researchers hope to stay one step ahead from now on with a new platform for detecting and analysing outbreaks.
Published: 13 January 2016
A major contribution to eradicating Ebola has been made by the EU-funded EVIDENT project. It has confirmed that the Ebola virus has mutated at a lower rate than feared during the recent outbreak in West Africa. This means that the new diagnostic methods, treatments and vaccines under development should still be effective in the fight to eradicate the disease.
Published: 24 July 2015